You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 273 No. 5, February 1, 1995 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLE
 This Article
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA

Serogroup C meningococcal outbreaks in the United States. An emerging threat

L. A. Jackson, A. Schuchat, M. W. Reeves and J. D. Wenger
Childhood and Respiratory Diseases Branch, Centers for Disease Control and Prevention, Atlanta, GA 30333.

OBJECTIVE--Multiple outbreaks of serogroup C Neisseria meningitidis have recently been reported from diverse areas of the United States. To better define the characteristics of this increasingly important problem, we reviewed data on all known serogroup C outbreaks in the United States from January 1980 through June 1993. DATA SOURCES--MEDLINE searches, Centers for Disease Control and Prevention records, state health department officials, infectious disease experts, and the meningococcal vaccine manufacturer. DEFINITION OF AN OUTBREAK--Three or more cases of serogroup C meningococcal disease within a 3-month period, either among members of a community or persons attending a single school or other institution, for which those cases represented an attack rate of at least five per 100,000 population. RESULTS--Twenty-one outbreaks of serogroup C meningococcal disease were identified; eight occurred since 1991. In 1992 and the first half of 1993, approximately 180,000 doses of vaccine were administered for outbreak control, compared with approximately 34,000 doses from 1980 to 1991. Approximately 50% of community-outbreak cases were between the ages of 5 and 24 years, compared with only 19% of sporadic serogroup C cases (P < .001). Subtyping of patient isolates indicates that outbreaks are clonal; however, at least five distinct but closely related strains have caused recent outbreaks. CONCLUSIONS--Serogroup C outbreaks are occurring more frequently in the United States. The effectiveness of preventive measures depends on early recognition; therefore, physicians should promptly report all cases of suspected meningococcal disease, and the causative serogroup should be established for every case.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

IS1301 Fingerprint Analysis of Neisseria meningitidis Strains Belonging to the ET-15 Clone
Elias and Vogel
J. Clin. Microbiol. 2007;45:159-167.
ABSTRACT | FULL TEXT  

Evidence for Indirect Nosocomial Transmission of Neisseria meningitidis Resulting in Two Cases of Invasive Meningococcal Disease
Elias et al.
J. Clin. Microbiol. 2006;44:4276-4278.
ABSTRACT | FULL TEXT  

Prospects for Vaccine Prevention of Meningococcal Infection
Harrison
Clin. Microbiol. Rev. 2006;19:142-164.
ABSTRACT | FULL TEXT  

Prevention and Control of Meningococcal Disease: Recommendations for Use of Meningococcal Vaccines in Pediatric Patients
Committee on Infectious Diseases
Pediatrics 2005;116:496-505.
ABSTRACT | FULL TEXT  

Molecular Epidemiological Analysis of the Changing Nature of a Meningococcal Outbreak following a Vaccination Campaign
Shlush et al.
J. Clin. Microbiol. 2002;40:3565-3571.
ABSTRACT | FULL TEXT  

Extremity Pain and Refusal to Walk in Children With Invasive Meningococcal Disease
Inkelis et al.
Pediatrics 2002;110:e3-3.
ABSTRACT | FULL TEXT  

Risk Factors for Meningococcal Disease in College Students
Bruce et al.
JAMA 2001;286:688-693.
ABSTRACT | FULL TEXT  

Invasive Meningococcal Disease in Adolescents and Young Adults
Harrison et al.
JAMA 2001;286:694-699.
ABSTRACT | FULL TEXT  

Toward Control of Meningococcal Disease: Reducing Risk in College Students
Wenger
JAMA 2001;286:720-721.
FULL TEXT  

Meningococcal Disease
Rosenstein et al.
NEJM 2001;344:1378-1388.
FULL TEXT  

Meningococcal group C conjugate vaccines
MAcLENNAN
Arch. Dis. Child. 2001;84:383-386.
FULL TEXT  

Evaluation of Pulsed-Field Gel Electrophoresis in Epidemiological Investigations of Meningococcal Disease Outbreaks Caused by Neisseria meningitidis Serogroup C
Popovic et al.
J. Clin. Microbiol. 2001;39:75-85.
ABSTRACT | FULL TEXT  

Meningococcal Disease Prevention and Control Strategies for Practice-Based Physicians (Addendum: Recommendations for College Students)
Committee on Infectious Diseases
Pediatrics 2000;106:1500-1504.
ABSTRACT | FULL TEXT  

Long-Term Persistence of a Discotheque-Associated Invasive Neisseria meningitidis Group C Strain as Proven by Pulsed-Field Gel Electrophoresis and porA Gene Sequencing
Riesbeck et al.
J. Clin. Microbiol. 2000;38:1638-1640.
ABSTRACT | FULL TEXT  

Changing carriage rate of Neisseria meningitidis among university students during the first week of term: cross sectional study
Neal et al.
BMJ 2000;320:846-849.
ABSTRACT | FULL TEXT  

Update on Meningococcal Disease with Emphasis on Pathogenesis and Clinical Management
van Deuren et al.
Clin. Microbiol. Rev. 2000;13:144-166.
ABSTRACT | FULL TEXT  

Cleavase Fragment Length Polymorphism Analysis of Neisseria meningitidis Basic Metabolic Genes
Tondella et al.
J. Clin. Microbiol. 1999;37:2402-2407.
ABSTRACT | FULL TEXT  

Risk of Meningococcal Infection in College Students
Harrison et al.
JAMA 1999;281:1906-1910.
ABSTRACT | FULL TEXT  

Epidemic Serogroup B Meningococcal Disease in Oregon: The Evolving Epidemiology of the ET-5 Strain
Diermayer et al.
JAMA 1999;281:1493-1497.
ABSTRACT | FULL TEXT  

Clinical and Hematologic Features Do Not Reliably Identify Children With Unsuspected Meningococcal Disease
Kuppermann et al.
Pediatrics 1999;103:20e-20.
ABSTRACT | FULL TEXT  

Age-Dependent Neisseria meningitidis Serogroup C Class-Specific Antibody Concentrations and Bactericidal Titers in Sera from Young Children from Montana Immunized with a Licensed Polysaccharide Vaccine
Maslanka et al.
Infect. Immun. 1998;66:2453-2459.
ABSTRACT | FULL TEXT  

Efficacy of Meningococcal Vaccine and Barriers to Vaccination
Rosenstein et al.
JAMA 1998;279:435-439.
ABSTRACT | FULL TEXT  

Meningococcal Disease and Public Health Practice: A Complicated Road Map
Moore and Osterholm
JAMA 1998;279:472-473.
FULL TEXT  

Bacterial Meningitis in the United States in 1995
Schuchat et al.
NEJM 1997;337:970-976.
ABSTRACT | FULL TEXT  

Preventative strategies on meningococcal disease
MAYON-WHITE and HEATH
Arch. Dis. Child. 1997;76:178-181.
FULL TEXT  

Capsule switching of Neisseria meningitidis
Swartley et al.
Proc. Natl. Acad. Sci. USA 1997;94:271-276.
ABSTRACT | FULL TEXT  

Meningococcal Disease in Los Angeles County, California, and among Men in the County Jails
Tappero et al.
NEJM 1996;335:833-841.
ABSTRACT | FULL TEXT  

Sporadic Meningococcal Disease in Adults: Results of a 5-Year Population-Based Study
Stephens et al.
ANN INTERN MED 1995;123:937-940.
ABSTRACT | FULL TEXT  

INCREASING OUTBREAKS OF GROUP C MENINGOCOCCAL DISEASE
JWatch General 1995;1995:3-3.
FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1995 American Medical Association. All Rights Reserved.